Exciting news in Beyond the Scope! #UCLAGI 🔹California Institute for #Immunology & Immunotherapy 🔹New #IBD multidisciplinary clinics 🔹#DGBI research & care 🔹#UCLAMicrobiome Center research & education 🔹New faculty 🔹Mellinkoff Symposium 2024 👉bit.ly/3UL8GNV

Good morning from Washington, D.C.! We’re joining Fight Colorectal Cancer and partners in the CRC community to raise awareness about the need to increase and protect access to screening. #UnitedInBlue

Congrats to our adv IBD Fellow Perseus Patel, MD on publication of his work in JPGN showing similar effectiveness of VDZ and UST in pediatric UC patients with prior TNFi exposure! Mel Heyman ImproveCareNow™ onlinelibrary.wiley.com/doi/10.1002/jp…

Anecdotally, many of us have noted improvement in IBD in setting of PSC with oral vancomycin. This study in roypounder.apt provides some support. Amanda Ricciuto onlinelibrary.wiley.com/doi/10.1111/ap…

🎧All New Episode: Dr. Maria Oliva-Hemker Maria Oliva-Hemker, MD from John Hopkins Johns Hopkins Medicine talks about #cdiff: 🎙️How to manage C. diff infection in #IBD 🎙️The history of C.diff 🎙️How C.diff changed from Clostridium difficile to Clostridioides difficile ✍️ Temara Hajjat, MD Peter L. Lu, MD, MS

Check out Miguel Regueiro highlight some of his favorite #IBD research at #DDW2024. Click the link to watch the full video! gastroendonews.com/Multimedia/Art…

Hot of the press: Upadacitinib safety in pregnancy. 128 maternal pregnacies all exposed in the first trimester primarily. MotherToBaby Mette Julsgaard Millie Long link.springer.com/article/10.100…

🌠#UCLAGI & GI surgery ranked #4 in @USNews Best Hospitals rankings! This also makes us the top ranked GI & GI surgery hospital for a public university in the country. We thank our patients for continuing to choose our dedicated and exemplary team to provide their care.

Dual biological therapy shows promise for treating children with severe, refractory #IBD. ✅ 45% achieved clinical remission within 12 months, offering a potential alternative for those failing previous treatments. #Pediatrics #Gastroenterology onlinelibrary.wiley.com/doi/10.1002/jp…

Guselkumab induced higher levels of clinical and endoscopic remission than placebo and ustekinumab in the GALAXI phase 2/3 trial. Remo Panaccione, MD, FRCPC IBD YYC Miguel Regueiro @clevelandclinic #IBDTwitter #IBD gastroendonews.com/a/MyMBAA/t

UCLA has been ranked the nation’s #1 public university by @USNews and World Report! 8 years in a row and it’s all thanks to you, Bruins.💙🐻💛 #1UCLA Learn more: ucla.in/4euYmAd

On Giving Tuesday, think of children living with chronic illnesses such as Inflammatory Bowel Disease 🙌🏽 vimeo.com/wwpvideo/revie…

Very nice synopsis on positioning therapies for the management of luminal #crohnsdisease #IBD by Uma Mahadevan at the Advances in IBD #AIBD2024

Happy Holidays from the UCLA Pediatric IBD Team! UCLA UCLA Center for IBD UCLAMattelChildrens

New study shows patients on GLP-1s have prolonged gastric transit time and incomplete small bowel evaluation during endoscopy, raising concerns about delayed gastric emptying and highlighting the need for more research. Tarek Odah gastroendonews.com/Endoscopy-Suit…

AAP joined @AAFP, @ACOG, ACP, AOA and American Psychiatric Association in urging the U.S. government to remain in the World Health Organization. Read the statement: bit.ly/3CpEfpF

Our fellows being rockstars at DDW! Digestive Disease Week

Thank you Crohn's & Colitis Foundation for an amazing Take Steps event! And UCLA Health for your support!

🎙️ New episode: Addressing Women’s Health in Pediatric IBD! From delayed puberty to contraception to fertility after surgery 🎧 CME credit available! #MedEd #IBD #WomensHealth #PedsGI #FOAMed buzzsprout.com/581062/episode…